Tirzepatide Matches Dulaglutide for Cardiovascular Protection With Added Metabolic Benefits: NEJM Dr Riya Dave22 Dec 2025 11:00 AM ISTIn a large randomized trial involving patients with type 2 diabetes and established atherosclerotic cardiovascular disease, tirzepatide was...
Unilateral Adrenalectomy Raises Long-Term CKD and Gout Risk in Primary Aldosteronism: Study Medha Baranwal21 Dec 2025 8:45 PM ISTTaiwan: A 20-year population study has revealed that patients with primary aldosteronism who undergo unilateral adrenalectomy face increased long-term...
Worsening Diabetes Complications Lower Quality of Life in Type 1 Diabetes, Suggests Study Medha Baranwal20 Dec 2025 9:30 AM ISTFrance: A study in Diabetes, Obesity and Metabolism found that adults with type 1 diabetes experienced a decline in health-related quality of life as...
ART Cycles Linked to Slight Increase in Cardiovascular Risk, Suggests Research Medha Baranwal20 Dec 2025 9:15 AM ISTNorway: Researchers have found in a new registry-based study that each additional cycle of assisted reproductive technology was associated with a...
Predicting who is at risk of developing type 1 diabetes, as new drugs now available: Lancet Dr. Kamal Kant Kohli20 Dec 2025 5:00 AM ISTA test using genetics to predict who is at the highest risk of developing type 1 diabetes could one day be applied to largescale health studies, to...
Semaglutide Significantly Improves Glycemia and Weight in Schizophrenia: JAMA Dr Riya Dave19 Dec 2025 8:45 PM ISTAccording to a new study published in JAMA Psychiatry, adjunctive semaglutide was shown to significantly improve glycemic control and weight outcomes...
World Health Organization Issues Guideline for Glucagon-like-Peptide-1 Therapies Use in Obesity: JAMA December 2025 Special Communication Dr. Bhumika Maikhuri19 Dec 2025 11:00 AM ISTA recent special communication highlighted that medication alone cannot solve the global obesity burden. The availability of GLP-1 therapies should...
GLP-1 Receptor Agonists Linked to Lower All-Cause Mortality in Hypertrophic Cardiomyopathy: AHJ, December 2025 Study Reveals New Cardiovascular Benefits Dr. Bhumika Maikhuri19 Dec 2025 10:30 AM ISTA recent study found that Glucagon-like peptide-1 (GLP-1) receptor agonist use in hypertrophic cardiomyopathy (HCM) patients with type 2 diabetes...
Lowering blood sugar cuts heart attack risk in people with prediabetes: Lancet Dr. Kamal Kant Kohli19 Dec 2025 10:00 AM ISTLowering blood sugar levels halves the likelihood of serious heart problems in people with prediabetes. According to King's College London research,...
TyG Index Strongly Predicts Subclinical Myocardial Injury, Especially in Diabetes: Study Jacinthlyn Sylvia19 Dec 2025 9:15 AM ISTA new study published in the journal of Cardiovascular Diabetology showed that for the first time, a U-shaped correlation was found between the...
Integrating Low-Cost Interventions: Yoga and Walking Demonstrate Significant Glycemic Benefit in Type 2 Diabetes Dr. Bhumika Maikhuri18 Dec 2025 12:15 PM ISTA recent study found a substantial time-dependent decrease in acute blood glucose levels (FBS and PPBS) in patients with type 2 diabetes, with the...
Incretin-Based Drugs Not Tied to Increased Risk of Acute Pancreatitis Among Diabetics: Study Medha Baranwal18 Dec 2025 8:45 AM ISTUSA: Researchers have found in a new study that among patients with type 2 diabetes, incretin-based medications (GLP-1 receptor agonists and DPP-4...
